logo
Breadcrumbs Image

Preimplantation Genetic Diagnostics PGD Market

Preimplantation Genetic Diagnostics PGD Market

Global Preimplantation Genetic Diagnostics (PGD) Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: May-2021 | Id: MACRC-69171 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Preimplantation Genetic Diagnostics (PGD) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report.
 The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
 
 By Market Verdors:
 Illumina, Inc.
 Rubicon Genomics
 Perkinelmer, Inc.
 Thermo Fisher Scientific Inc.
 Natera, Inc.
 Agilent Technologies, Inc.
 Yikon Genomics
 ABBott Laboratories
 Cooper Surgical
 Oxford Gene Technology
 FUJIFILM Irvine Scientific
 Merck
 Scigene
 IVFtech
 Nidacon International
 Hamilton Thorne
 Beijing Genomics Institute (BGI)
 INVO Bioscience
 Vitrolife AB
 Genea Limited
 Gonagen Medikal
 Cook Medical
 CellCura
 
 By Types:
 Preimplantation Genetic Screening
 Preimplantation Genetic Diagnosis
 
 By Applications:
 Fertility Clinics
 Academic Medical Centers
 Others
 
 Key Indicators Analysed
 Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
 Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
 Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
 Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
 Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
 
 Key Reasons to Purchase
 To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
 Assess the production processes, major issues, and solutions to mitigate the development risk.
 To understand the most affecting driving and restraining forces in the market and its impact in the global market.
 Learn about the market strategies that are being adopted by leading respective organizations.
 To understand the future outlook and prospects for the market.
 Besides the standard structure reports, we also provide custom research according to specific requirements.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
 1.1 Study Scope and Definition
 1.2 Research Methodology
 1.2.1 Methodology/Research Approach
 1.2.2 Data Source
 1.3 Key Market Segments
 1.4 Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue
 1.5 Market Analysis by Type
 1.5.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type: 2021 VS 2027
 1.5.2 Preimplantation Genetic Screening
 1.5.3 Preimplantation Genetic Diagnosis
 1.6 Market by Application
 1.6.1 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2022-2027
 1.6.2 Fertility Clinics
 1.6.3 Academic Medical Centers
 1.6.4 Others
 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
 1.7.2 Covid-19 Impact: Commodity Prices Indices
 1.7.3 Covid-19 Impact: Global Major Government Policy
 1.8 Study Objectives
 1.9 Years Considered
 2 Global Preimplantation Genetic Diagnostics (PGD) Market Trends and Growth Strategy
 2.1 Market Top Trends
 2.2 Market Drivers
 2.3 Market Challenges
 2.4 Porter’s Five Forces Analysis
 2.5 Market Growth Strategy
 2.6 SWOT Analysis
 3 Global Preimplantation Genetic Diagnostics (PGD) Market Players Profiles
 3.1 Illumina, Inc.
 3.1.1 Illumina, Inc. Company Profile
 3.1.2 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.2 Rubicon Genomics
 3.2.1 Rubicon Genomics Company Profile
 3.2.2 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.2.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.3 Perkinelmer, Inc.
 3.3.1 Perkinelmer, Inc. Company Profile
 3.3.2 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.3.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.4 Thermo Fisher Scientific Inc.
 3.4.1 Thermo Fisher Scientific Inc. Company Profile
 3.4.2 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.4.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.5 Natera, Inc.
 3.5.1 Natera, Inc. Company Profile
 3.5.2 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.5.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.6 Agilent Technologies, Inc.
 3.6.1 Agilent Technologies, Inc. Company Profile
 3.6.2 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.6.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.7 Yikon Genomics
 3.7.1 Yikon Genomics Company Profile
 3.7.2 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.7.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.8 ABBott Laboratories
 3.8.1 ABBott Laboratories Company Profile
 3.8.2 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.8.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.9 Cooper Surgical
 3.9.1 Cooper Surgical Company Profile
 3.9.2 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.9.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.10 Oxford Gene Technology
 3.10.1 Oxford Gene Technology Company Profile
 3.10.2 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.10.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.11 FUJIFILM Irvine Scientific
 3.11.1 FUJIFILM Irvine Scientific Company Profile
 3.11.2 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.11.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.12 Merck
 3.12.1 Merck Company Profile
 3.12.2 Merck Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.12.3 Merck Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.13 Scigene
 3.13.1 Scigene Company Profile
 3.13.2 Scigene Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.13.3 Scigene Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.14 IVFtech
 3.14.1 IVFtech Company Profile
 3.14.2 IVFtech Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.14.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.15 Nidacon International
 3.15.1 Nidacon International Company Profile
 3.15.2 Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.15.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.16 Hamilton Thorne
 3.16.1 Hamilton Thorne Company Profile
 3.16.2 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.16.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.17 Beijing Genomics Institute (BGI)
 3.17.1 Beijing Genomics Institute (BGI) Company Profile
 3.17.2 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.17.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.18 INVO Bioscience
 3.18.1 INVO Bioscience Company Profile
 3.18.2 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.18.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.19 Vitrolife AB
 3.19.1 Vitrolife AB Company Profile
 3.19.2 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.19.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.20 Genea Limited
 3.20.1 Genea Limited Company Profile
 3.20.2 Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.20.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.21 Gonagen Medikal
 3.21.1 Gonagen Medikal Company Profile
 3.21.2 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.22 Cook Medical
 3.22.1 Cook Medical Company Profile
 3.22.2 Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.23 CellCura
 3.23.1 CellCura Company Profile
 3.23.2 CellCura Preimplantation Genetic Diagnostics (PGD) Product Specification
 3.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 4 Global Preimplantation Genetic Diagnostics (PGD) Market Competition by Market Players
 4.1 Global Preimplantation Genetic Diagnostics (PGD) Production Capacity Market Share by Market Players (2016-2021)
 4.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Market Players (2016-2021)
 4.3 Global Preimplantation Genetic Diagnostics (PGD) Average Price by Market Players (2016-2021)
 5 Global Preimplantation Genetic Diagnostics (PGD) Production by Regions (2016-2021)
 5.1 North America
 5.1.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.1.2 Preimplantation Genetic Diagnostics (PGD) Key Players in North America (2016-2021)
 5.1.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.1.4 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 5.2 East Asia
 5.2.1 East Asia Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.2.2 Preimplantation Genetic Diagnostics (PGD) Key Players in East Asia (2016-2021)
 5.2.3 East Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.2.4 East Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 5.3 Europe
 5.3.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.3.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Europe (2016-2021)
 5.3.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.3.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 5.4 South Asia
 5.4.1 South Asia Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.4.2 Preimplantation Genetic Diagnostics (PGD) Key Players in South Asia (2016-2021)
 5.4.3 South Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.4.4 South Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 5.5 Southeast Asia
 5.5.1 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.5.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Southeast Asia (2016-2021)
 5.5.3 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.5.4 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 5.6 Middle East
 5.6.1 Middle East Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.6.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Middle East (2016-2021)
 5.6.3 Middle East Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.6.4 Middle East Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 5.7 Africa
 5.7.1 Africa Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.7.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Africa (2016-2021)
 5.7.3 Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.7.4 Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 5.8 Oceania
 5.8.1 Oceania Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.8.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Oceania (2016-2021)
 5.8.3 Oceania Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.8.4 Oceania Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 5.9 South America
 5.9.1 South America Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.9.2 Preimplantation Genetic Diagnostics (PGD) Key Players in South America (2016-2021)
 5.9.3 South America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.9.4 South America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 5.10 Rest of the World
 5.10.1 Rest of the World Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2021)
 5.10.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Rest of the World (2016-2021)
 5.10.3 Rest of the World Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
 5.10.4 Rest of the World Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
 6 Global Preimplantation Genetic Diagnostics (PGD) Consumption by Region (2016-2021)
 6.1 North America
 6.1.1 North America Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 6.1.2 United States
 6.1.3 Canada
 6.1.4 Mexico
 6.2 East Asia
 6.2.1 East Asia Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 6.2.2 China
 6.2.3 Japan
 6.2.4 South Korea
 6.3 Europe
 6.3.1 Europe Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 6.3.2 Germany
 6.3.3 United Kingdom
 6.3.4 France
 6.3.5 Italy
 6.3.6 Russia
 6.3.7 Spain
 6.3.8 Netherlands
 6.3.9 Switzerland
 6.3.10 Poland
 6.4 South Asia
 6.4.1 South Asia Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 6.4.2 India
 6.5 Southeast Asia
 6.5.1 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 6.5.2 Indonesia
 6.5.3 Thailand
 6.5.4 Singapore
 6.5.5 Malaysia
 6.5.6 Philippines
 6.6 Middle East
 6.6.1 Middle East Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 6.6.2 Turkey
 6.6.3 Saudi Arabia
 6.6.4 Iran
 6.6.5 United Arab Emirates
 6.7 Africa
 6.7.1 Africa Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 6.7.2 Nigeria
 6.7.3 South Africa
 6.8 Oceania
 6.8.1 Oceania Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 6.8.2 Australia
 6.9 South America
 6.9.1 South America Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 6.9.2 Brazil
 6.9.3 Argentina
 6.10 Rest of the World
 6.10.1 Rest of the World Preimplantation Genetic Diagnostics (PGD) Consumption by Countries
 7 Global Preimplantation Genetic Diagnostics (PGD) Production Forecast by Regions (2022-2027)
 7.1 Global Forecasted Production of Preimplantation Genetic Diagnostics (PGD) (2022-2027)
 7.2 Global Forecasted Revenue of Preimplantation Genetic Diagnostics (PGD) (2022-2027)
 7.3 Global Forecasted Price of Preimplantation Genetic Diagnostics (PGD) (2022-2027)
 7.4 Global Forecasted Production of Preimplantation Genetic Diagnostics (PGD) by Region (2022-2027)
 7.4.1 North America Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.4.2 East Asia Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.4.3 Europe Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.4.4 South Asia Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.4.5 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.4.6 Middle East Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.4.7 Africa Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.4.8 Oceania Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.4.9 South America Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.4.10 Rest of the World Preimplantation Genetic Diagnostics (PGD) Production, Revenue Forecast (2022-2027)
 7.5 Forecast by Type and by Application (2022-2027)
 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
 7.5.2 Global Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Application (2022-2027)
 8 Global Preimplantation Genetic Diagnostics (PGD) Consumption Forecast by Regions (2022-2027)
 8.1 North America Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
 8.2 East Asia Market Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
 8.3 Europe Market Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Countriy
 8.4 South Asia Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
 8.5 Southeast Asia Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
 8.6 Middle East Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
 8.7 Africa Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
 8.8 Oceania Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
 8.9 South America Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
 8.10 Rest of the world Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
 9 Global Preimplantation Genetic Diagnostics (PGD) Sales by Type (2016-2027)
 9.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Type (2016-2021)
 9.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2022-2027)
 10 Global Preimplantation Genetic Diagnostics (PGD) Consumption by Application (2016-2027)
 10.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Application (2016-2021)
 10.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2022-2027)
 11 Global Preimplantation Genetic Diagnostics (PGD) Manufacturing Cost Analysis
 11.1 Preimplantation Genetic Diagnostics (PGD) Key Raw Materials Analysis
 11.1.1 Key Raw Materials
 11.2 Proportion of Manufacturing Cost Structure
 11.3 Manufacturing Process Analysis of Preimplantation Genetic Diagnostics (PGD)
 12 Global Preimplantation Genetic Diagnostics (PGD) Marketing Channel, Distributors, Customers and Supply Chain
 12.1 Marketing Channel
 12.2 Preimplantation Genetic Diagnostics (PGD) Distributors List
 12.3 Preimplantation Genetic Diagnostics (PGD) Customers
 12.4 Preimplantation Genetic Diagnostics (PGD) Supply Chain Analysis
 13 Analyst's Viewpoints/Conclusions
 14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00